Cargando…
Antibody‐dependent Cytotoxicity Mediated by Chimeric Monoclonal Antibody Nd2 and Experimental Immunotherapy for Pancreatic Cancer
In a previous study, mouse monoclonal antibody (MoAb) Nd2 (m‐Nd2, mouse IgGl) labeled with (131) I exhibited efficacy in in vivo radioimmunotherapy against pancreatic cancer. In this study we prepared mouse/human chimeric antibody Nd2 (c‐Nd2, human IgG1) for clinical use and examined whether c‐Nd2 i...
Autores principales: | Nishihara, Tamahiro, Sawada, Tetsuji, Yamamoto, Atsushi, Yamashita, Yoshito, Ho, Jenny J. L., Kim, Young‐Sik, Chung, Kosei Hirakawa‐YS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926427/ https://www.ncbi.nlm.nih.gov/pubmed/10965023 http://dx.doi.org/10.1111/j.1349-7006.2000.tb01019.x |
Ejemplares similares
-
Preoperative Clinical Radioimmunodetection of Pancreatic Cancer by (111)In‐labeled Chimeric Monoclonal Antibody Nd2
por: Sawada, Tetsuji, et al.
Publicado: (1999) -
Radioimmunodetection with (111)In–labeled Monoclonal Antibody Nd2 in Patients with Pancreatic Cancer
por: Chung, Yong‐Suk, et al.
Publicado: (1997) -
Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice
por: Inui, Akimasa, et al.
Publicado: (1996) -
Production, Binding and Cytotoxicity of Human/Mouse Chimeric Monoclonal Antibody‐Neocarzinostatin Conjugate
por: Yamaguchi, Toshiharu, et al.
Publicado: (1993) -
Development and Characterization of Chimeric Anti‐carcinoembryonic Antigen Monoclonal Antibodies and Their Fab Fragments
por: Kamigaki, Takashi, et al.
Publicado: (1994)